Urinary Peptidomic Biomarker for Personalized Prevention and Treatment of Diastolic Left Ventricular Dysfunction-Reference-Cited by-同舟云学术

Urinary Peptidomic Biomarker for Personalized Prevention and Treatment of Diastolic Left Ventricular Dysfunction

Published:2019-02-18 Issue:2 Volume:13 Page:1800174
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Zhang Zhen‐Yu¹,Nkuipou‐Kenfack Esther²,Staessen Jan A.¹^ORCID

Affiliation:

1. Studies Coordinating CentreResearch Unit Hypertension and Cardiovascular EpidemiologyKU Leuven Department of Cardiovascular SciencesUniversity of Leuven Leuven Belgium

2. Mosaiques Diagnostic and Therapeutics AG Hannover Germany

Funder

H2020 European Research Council

Fonds Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.201800174

Reference53 articles.

1. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

2. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

3. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

4. Prevalence of Left Ventricular Diastolic Dysfunction in a General Population

5. Prevalence of left ventricular diastolic dysfunction in European populations based on cross-validated diagnostic thresholds

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic mesoporous materials and MALDI-TOF MS in peptidomics: From enrichment techniques to disease applications;TrAC Trends in Analytical Chemistry;2024-06

2. Development and validation of machine learning models for diagnosis and prognosis of cancer by urinary proteomics, based on the FLEMENGHO cohort;American Journal of Cancer Research;2024

3. Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study;Pharmaceuticals;2023-09-14

4. Tutorial review for peptide assays: An ounce of pre-analytics is worth a pound of cure;Journal of Chromatography B;2023-09

5. Prognosis and personalizedin-silicoprediction of treatment efficacy in cardiovascular and chronic kidney disease: a proof-of-concept study;2023-08-06